Cargando…
Synthesis of New Branched 2-Nitroimidazole as a Hypoxia Sensitive Linker for Ligand-Targeted Drugs of Paclitaxel
[Image: see text] Because of the low selectivity and efficiency of normal antitumor agents, the strategy of ligand-targeted drugs was put forward. In this paper, we designed and synthesized a new bioreductive linker based on 2-nitroimidazole, which was used in three paclitaxel (PTX) prodrugs. The dr...
Autores principales: | Zhang, Qiumeng, Jin, Chen, Yu, Jiahui, Lu, Wei |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American
Chemical Society
2018
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6644517/ https://www.ncbi.nlm.nih.gov/pubmed/31459014 http://dx.doi.org/10.1021/acsomega.8b01208 |
Ejemplares similares
-
Synthesis and Evaluation of (99m)Tc-Labelled 2-Nitroimidazole Derivatives with Different Linkers for Tumour Hypoxia Imaging
por: Ruan, Qing, et al.
Publicado: (2023) -
Synthesis of New Active Sulfones in the 5-Nitroimidazole Series
por: Benakli, Kamel, et al.
Publicado: (2002) -
Synthesis and Biological Evaluation of a New Nitroimidazole-(99m)Tc-Complex for Imaging of Hypoxia in Mice Model
por: Zhang, Qing, et al.
Publicado: (2016) -
Synthesis and Preliminary Evaluation of a Novel (18)F-Labeled 2-Nitroimidazole Derivative for Hypoxia Imaging
por: Lu, Jing, et al.
Publicado: (2021) -
Design and Synthesis of Vandetanib Derivatives Containing Nitroimidazole Groups as Tyrosine Kinase Inhibitors in Normoxia and Hypoxia
por: Wei, Huiqiang, et al.
Publicado: (2016)